Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study

dc.contributor.author	Lauridsen, Camilla
dc.contributor.author	Sando, Sigrid Botne
dc.contributor.author	Shabnam, Adiba
dc.contributor.author	Møller, Ina
dc.contributor.author	Berge, Guro
dc.contributor.author	Grøntvedt, Gøril Rolfseng
dc.contributor.author	Bakken, Inger Johanne
dc.contributor.author	Salvesen, Øyvind
dc.contributor.author	Bråthen, Geir
dc.contributor.author	White, Linda
dc.date.accessioned	2016-05-23T11:45:44Z
dc.date.accessioned	2016-07-13T08:16:57Z
dc.date.available	2016-05-23T11:45:44Z
dc.date.available	2016-07-13T08:16:57Z
dc.date.issued	2016
dc.identifier.citation	Frontiers in Aging Neuroscience 2016, 8
dc.identifier.issn	1663-4365
dc.identifier.uri	http://hdl.handle.net/11250/2396414
dc.description	-
dc.language.iso	eng
dc.relation.uri	http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772322/pdf/fnagi-08-00030.pdf
dc.title	Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study
dc.type	Journal article
dc.date.updated	2016-05-23T11:45:44Z
dc.identifier.doi	10.3389/fnagi.2016.00030
dc.identifier.cristin	1356933